Trials / Completed
CompletedNCT00257478
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM155 |
Timeline
- Completion
- 2007-03-01
- First posted
- 2005-11-23
- Last updated
- 2012-06-07
Locations
9 sites across 3 countries: United States, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT00257478. Inclusion in this directory is not an endorsement.